Affiliation:
1. Department of General Surgery, Lanzhou University Second Hospital, Lanzhou, China
2. Lanzhou University Second Hospital, Lanzhou, China
3. Cuiying Biomedical Research Center, Lanzhou University Second Hospital, Lanzhou, China
Abstract
Src homolog and collagen homolog (Shc) proteins have been identified as adapter proteins
associated with cell surface receptors and have been shown to play important roles in signaling
and disease. Shcbp1 acts as a Shc SH2-domain binding protein 1 and is involved in the regulation of
signaling pathways, such as FGF, NF-κB, MAPK/ERK, PI3K/AKT, TGF-β1/Smad and β -catenin
signaling. Shcbp1 participates in T cell development, the regulation of downstream signal transduction
pathways, and cytokinesis during mitosis and meiosis. In addition, Shcbp1 has been demonstrated
to correlate with Burkitt-like lymphoma, breast cancer, lung cancer, gliomas, synovial sarcoma,
human hepatocellular carcinoma and other diseases. Shcbp1 may play an important role in
tumorigenesis and progression. Accordingly, recent studies are reviewed herein to discuss and interpret
the role of Shcbp1 in normal cell proliferation and differentiation, tumorigenesis and progression,
as well as its interactions with proteins.
Funder
Gansu Provincial Key Research and Development Program
Publisher
Bentham Science Publishers Ltd.
Subject
Cancer Research,Drug Discovery,Pharmacology,Oncology
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献